Essity AB Class B is a leading global hygiene and health company, primarily operating in Europe and North America. Its product portfolio includes well-known brands such as TENA and Libero, which provide a competitive edge through strong brand loyalty and innovation in personal care and tissue products.
Essity generates revenue through the sale of hygiene and health products, leveraging strong brand recognition and economies of scale to maintain pricing power. The company benefits from a diversified product range and a global distribution network, allowing it to adapt to regional market demands.
Changes in raw material costs, particularly pulp and plastic prices
Consumer demand trends in hygiene products, influenced by demographic shifts
Currency fluctuations impacting international sales
Regulatory changes affecting product standards and safety
Increased competition from private label and discount brands
Regulatory changes in sustainability and product safety standards
Market share loss to competitors with lower pricing strategies
Innovation lag in product development compared to agile startups
Potential liquidity issues if free cash flow declines significantly
Exposure to currency risk due to international operations
moderate - The company is somewhat sensitive to economic cycles as consumer spending on hygiene products can fluctuate with economic conditions, but essential nature of products provides some insulation.
Interest rates affect Essity through the cost of financing for capital expenditures and working capital. Higher rates could increase borrowing costs, impacting profitability and investment decisions.
minimal - Essity's low debt-to-equity ratio of 0.46 indicates a strong balance sheet and limited reliance on credit markets.
value - Investors may be drawn to Essity for its stable cash flows and dividend yield, despite recent revenue declines.
low - The stock has historically shown low volatility, with a beta around 0.8.